Absci Corp (ABSI)
4.58
+0.12
(+2.81%)
USD |
NASDAQ |
Apr 26, 16:00
4.575
0.00 (0.00%)
After-Hours: 20:00
Absci Profit Margin (Quarterly): -6.97K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.97K% |
| September 30, 2023 | -2.96K% |
| June 30, 2023 | -1.24K% |
| March 31, 2023 | -1.84K% |
| December 31, 2022 | -1.25K% |
| September 30, 2022 | -1.15K% |
| June 30, 2022 | -2.86K% |
| March 31, 2022 | -3.60K% |
| Date | Value |
|---|---|
| December 31, 2021 | -1.73K% |
| September 30, 2021 | -1.54K% |
| June 30, 2021 | -5.66K% |
| March 31, 2021 | -1.03K% |
| December 31, 2020 | -181.0% |
| September 30, 2020 | -409.2% |
| June 30, 2020 | -533.3% |
| March 31, 2020 | -464.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.97K%
Minimum
Dec 2023
-181.0%
Maximum
Dec 2020
-2.09K%
Average
-1.39K%
Median
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 9.36% |
| Eli Lilly and Co | 23.41% |
| Creative Medical Technology Holdings Inc | -55.95K% |
| HOOKIPA Pharma Inc | -335.1% |
| Recursion Pharmaceuticals Inc | -875.3% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -49.52% |
| Return on Assets | -41.74% |
| Return on Invested Capital | -47.50% |
| Operating Margin (Quarterly) | -7.32K% |
| Return on Net Operating Assets | -98.17% |